Fertomid 100

Fertomid 100 by Cipla is a pharmaceutical-grade Selective Estrogen Receptor Modulator (SERM) containing pure Clomiphene Citrate at a potent concentration of 100mg per tablet. Manufactured by Cipla—a global leader in healthcare and pharmaceutical formulation—Fertomid 100 is produced under strict Good Manufacturing Practice (GMP) standards to deliver consistent chemical purity, stability, and high oral bioavailability.

Clomiphene Citrate operates primarily as a competitive estrogen receptor antagonist at the hypothalamic and pituitary level. In performance and athletic contexts, Fertomid 100 is a cornerstone agent used during Post Cycle Therapy (PCT) to reactivate the Hypothalamic-Pituitary-Testicular Axis (HPTA), driving the body to resume its own production of Luteinizing Hormone (LH) and endogenous testosterone following suppressive anabolic steroid or SARM cycles.

Key Benefits & Applications

• Rapid HPTA & Endogenous Testosterone Recovery: Directly blocks central estrogenic negative feedback, triggering a rapid surge in Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) to kickstart dormant Leydig cells post-cycle.

• Potent 100mg Concentration: High tablet strength designed specifically for the high-dose “front-loading” or initial loading phase during the first week of Post Cycle Therapy (PCT).

• Spermatogenesis Stimulation: Up-regulates pituitary FSH output, helping restore intratesticular testicular environment, sperm count, and seminal volume post-suppression.

• Preservation of Lean Muscle Mass: By accelerating natural testosterone production, Fertomid 100 prevents the severe catabolic crash and muscle loss that can occur when clearing exogenous hormones.

• Synergistic PCT Compatibility: Works exceptionally well when combined with secondary SERMs (such as Tamoxifen/Altamofen) to ensure complete endocrine recovery across multiple receptor pathways.